Ads
related to: cure for hepatitis c/ $1000 per dose- Hep C Treatment Info
Ready To Treat Your Hep C?
Learn About A Treatment Option Here
- Risks Of Hepatitis C
Read About The Risks Of Hep C And
Explore A Hep C Treatment Here.
- Download A Co-Pay Coupon
Eligible Patients May Pay As Little
As $5 Per Co-Pay For A Treatment
- Talk To Your Provider
Download A Conversation Guide And
Learn About A Treatment Option Here
- Find A Hep C Provider
Ready To Take The Next Step? Find
A Hep C Provider Near You Today!
- Patient Support Program
Looking For Financial Assistance &
Insurance Support? Learn More Here.
- Hep C Treatment Info
Search results
Results From The WOW.Com Content Network
On one hand, this agent offers up to a 95% response rate as part of an interferon-free treatment regimen for hepatitis C. Generally speaking, it is more effective and better tolerated than alternative treatments. Unfortunately, the current per pill cost—$1,000—results in an $84,000 treatment course, creating barriers to therapy for many.
Medicare Part A may cover any in-hospital treatment for hepatitis C in full. ... pill costs around $1,000, and the cost of a 12-week course of Sovaldi reaches around $84,000.
Direct-acting antivirals can cure one of the nation's deadliest bloodborne diseases. But Medicaid restrictions and other barriers stand in the way. We have a cure for hepatitis C.
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.
For premium support please call: 800-290-4726 more ways to reach us
Raymond F. Schinazi (born 21 March 1950) is an Egyptian organic medicinal chemist.He is the Frances Winship Walters Professor of Pediatrics at Emory University.He has expertise in antiviral agents, pharmacology, and biotechnology.
Ads
related to: cure for hepatitis c/ $1000 per dose